Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2020/09/14/3-stocks-making-major-buyout-buzz-today

9/14/2020 1:55 PM

A number of announcements regarding buyout offers for the entirety of -- or at least a large stake in -- various companies is kicking the week off at a rapid pace today. Specifically, biotech Immunome...

Option Traders Blast Gilead Sciences Stock After IMMU Deal

https://www.schaeffersresearch.com/content/news/2020/09/14/option-traders-blast-gilead-sciences-stock-after-immu-deal

9/14/2020 11:55 AM

It's been a whirlwind start to the week, with dealmaking dominating the headlines. One of the more notable is Gilead Sciences, Inc. (NASDAQ:GILD) and their acquisition of Immunomedics (IMMU) for $21 b...

Signal Says Drug Stock Not Done Climbing

https://www.schaeffersresearch.com/content/analysis/2019/12/10/signal-says-drug-stock-not-done-climbing

12/10/2019 2:30 PM

It's been a hot start to December for Immunomedics, Inc. (NASDAQ:IMMU). The pharmaceutical stock is up 11.5% already this month, and earlier today nabbed a fresh annual high of $21.49. Heading into t...

Stock Futures Signal Strong End to September

https://www.schaeffersresearch.com/content/ezines/2019/09/30/stock-futures-signal-strong-end-to-september

9/30/2019 9:11 AM

Reports suggesting the White House wanted to curb capital flows to China sparked a bearish reversal in stocks on Friday. This morning, though, futures on the Dow Jones Industrial Average (DJI) are...

Drug Stock With Cheap Options Sounds Bear Signal

https://www.schaeffersresearch.com/content/analysis/2019/07/23/drug-stock-with-cheap-options-sounds-bear-signal

7/23/2019 11:46 AM

Immunomedics, Inc. (NASDAQ:IMMU) stock topped out at an annual high of $26.99 on Sept. 4, before sliding to a 13-month low of $11.55 by mid-January. A rebound attempt was quickly rejected by the drug...

PEOPLE ALSO SEARCH FOR